
B6 class action raises concerns for pregnant women and supplement safety
More than 1,000 Australians have contacted lawyers about neurological symptoms they believe are linked to excessive B6 in over-the-counter supplements, many marketed as safe multivitamins or magnesium blends.
Among them is 33-year-old Dominic Noonan O'Keefe, a father from Victoria, who started taking supplements to prepare for the arrival of his baby daughter.
'The main motivation was my daughter's coming. I want to be as ready as possible for that period,' he said.
He says what followed was months of escalating, unexplained symptoms including nerve pain, loss of balance, visual issues and overwhelming fatigue.
"I remember standing at my desk and I had this electric shock of nerve pain shoot up in my scalp. Everything became overwhelming. I couldn't deal with it. The light was too bright. The noises were too loud ... I thought I was having an aneurysm or something ... I thought I was dying"
Dominic continued to deteriorate over several months as specialists searched for answers, but routine tests failed to check his B6 levels. The turning point came not from the medical system, but a family barbecue.
'My whole family knew I was incredibly unwell ... I just said, 'Oh, my arms are just so numb and they feel like they're vibrating…' and [my stepsister] stopped for a second, she's like, 'Are you taking any supplements?' he said.
'She flipped me some peer-reviewed literature ... and immediately I knew what was going on.
'The next day I got a blood test and my results were double what they needed to be for peripheral neuropathy, which is just shorthand for nerve damage.'
Polaris principal lawyer Nick Mann is leading the proposed class action against Blackmores. He says the firm has now received more than 20 inquiries from women who were pregnant or breastfeeding while taking B6-containing supplements.
"You could be taking a pregnancy multivitamin and a magnesium supplement combined. You could have 50, 60 times the recommended daily intake of B6."
'To date, we've also received about 20 inquiries from women who were taking multivitamins while pregnant or breastfeeding. That's something that we're investigating.'
Mann believes this is just the beginning of what could be a much larger health issue, driven by regulatory gaps and marketing practices within the supplement industry.
'What we've since discovered is that there are thousands of Australians out there who are likely to have been affected by this,' Mann said.
While most people associate vitamin supplements with health benefits, B6 — also known as pyridoxine — can accumulate in the body over time, particularly if consumed through multiple sources.
'One of the things that I think the companies haven't well understood or appreciated is that you could be taking a few different supplements at the same time ... you could be taking 50 times the recommended daily intake of B6,' he said.
'We are yet to see any convincing evidence that it needs to be in these supplement. You can go down to your local chemist and find an almost identical product which contains magnesium as the primary supplement sitting next to one that contains 30 to 40 times the recommended daily intake of B6.'
A spokesperson for Blackmores has told 7NEWS it's committed to the 'highest standards of product quality and consumer safety'.
'All our products, including those containing vitamin B6, are developed in strict accordance with the safety and regulatory requirements of the Therapeutic Goods Administration (TGA).
'This includes compliance with maximum permitted daily doses and the inclusion of mandated warning statements on product labels. We acknowledge the interim decision issued by the TGA and we will ensure full compliance with its final determination, prioritising the safety of our products.
'Vitamin B6 is in a range of products within the vitamins and dietary supplement industry and its inclusion in some Blackmores products is consistent with industry practice and meets current regulatory requirements in all markets.'
Dominic is one of the first to come forward and says he hopes speaking out will prompt real change.
'I feel embarrassed initially and a bit of shame like I think everyone does ... there's a part of you that realises you were doing it, you were taking the supplements and unknowingly poisoning yourself,' he said.
'You can go into chemists still to this day and there won't be warning labels. I didn't have the luxury of that on any of my supplements. There are still supplements to this day in chemists without warnings on them.'
"This whole thing doesn't seem right and I think we need to do something about it."
Mann says the proposed legal action is the first B6 class action of its kind globally. It's gaining international attention and even prompting whistleblowers from inside the supplement industry to come forward.
"This is the first class action in the world that's been brought in relation to B6 toxicity. "
'We're proud to bring it.
'What I can say so far is that from those inquiries, what we understand is that there was a huge reliance on what was approved by the TGA, but then no other consideration of safety and efficacy.
"The regulation of complementary medicines in Australia seems to have followed what's called a light-touch regulatory approach."
Mann stresses that their legal case is not against the regulator, but against the companies with a duty of care to protect the public.
'The TGA regulation doesn't and can't be the beginning and the and of the legal liability ... You can't, at law, say, well the regulator allowed us to do this and so therefore that's our legal liability.'
Vitamin B6 is also added to food and drinks particularly breakfast cereals, protein bars and energy drinks.
Dr Terri-Lynne South from the Royal Australian College of General Practitioners says there needs to be better regulation in the food industry.
"There needs to be better regulation of those energy drinks because it is quite high. "
'There needs to be education and potentially some recommendations to pull them in line with what we're seeing in those vitamin and mineral supplements.'
The TGA also responded to 7NEWS enquires: 'The TGA has alerted consumers to the risk of neuropathy from vitamin B6, including a safety alert in 2022.
'Since March 2022, medicines providing over 10 mg equivalent vitamin B6 per day have required the label warning statement: 'WARNING - Stop taking this medication if you experience tingling, burning or numbness and see your healthcare practitioner as soon as possible. [Contains vitamin B6].'
'In June, the TGA released an interim decision that proposes to change the current scheduling of vitamin B6 (pyridoxine, pyridoxal and pyridoxamine) such that oral preparations containing 50 mg or less per recommended daily dose are available for general retail sale (unscheduled).
'Oral preparations containing more than 50 mg but less than 200 mg per recommended daily dose would become Pharmacist only medicines (Schedule 3). This decision, if implemented, will reduce the maximum amount of vitamin B6 allowed in oral products than currently available for general sale.
'The interim decision balances the risks and benefits of using vitamin B6 including the risk of peripheral neuropathy, acknowledging its potential for irreversible harm at higher doses and variability in individual metabolism. It also considers the limited clinical need for supplementation due to dietary sufficiency, alongside the widespread use of vitamin B6 in fortified products and listed medicines.'
Dominic, now a year into recovery, still faces flare-ups triggered by illness or stress and lasting symptoms like numbness, vision problems, and fatigue.
'It feels like a heavy veil is over me and I've receded back into myself and I'm sort of just operating something that doesn't a body that doesn't work. But when I feel good, I feel present again,' he said.
'I feel me today.'
For him, the fight is about protecting others.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


West Australian
11 hours ago
- West Australian
Queensland deputy premier satisfied with low flu vaccination rates as cases soar
Health authorities are urging Australians to still get a flu shot but Queensland Deputy Premier Jarrod Bleijie says he is satisfied with his state's flu vaccine rates, which have toppled to new lows amid increasing flu-related hospitalisations. The state is facing a surge in infections this flu season, with more than 44,000 lab-confirmed cases confirmed in the state this year – 20 per cent higher than the year before. Queensland Health reported 106 flu-related deaths this year until August 9, which is 12 more than the same time last year. Pharmacy Guild of Australia president Chris Owen said 86 per cent of people hospitalised with the flu had not been vaccinated. 'You can't argue with the numbers,' he said in a statement, adding '86 per cent of people hospitalised with flu weren't vaccinated and 90 per cent of reported cases hadn't had the vaccine'. 'The message is clear: get to your community pharmacy and get vaccinated.' On Tuesday, Mr Bleijie told reporters his vaccination status was a 'private matter between me and my doctor'. 'We're not going to be a government, like former governments, dictating what people do in their own homes, their own lives or with their doctors,' he said, referring to Covid-19 restrictions and vaccination mandates. 'If people want to get the flu vaccination they are entitled to do that, I'm not going to dictate whether they should do it or not. 'We will deal with the influx of people in the hospitals, just as the health minister has been doing, with our wonderful doctors and nurses on the frontline.' Australian Medical Association president Nick Yim said the increased flu-related cases were adding to the already overrun healthcare system. 'The cases are rising, hospitalisations are rising due to influenza and that's due to the fact that many people aren't vaccinated,' Dr Yim told Weekend Today. 'And that, unfortunately, is putting pressure on our healthcare system.' He said hospitals were forced to postpone elective surgeries due to the increasing number of flu cases. 'The reason why we had to postpone elective surgery was to give a bit of breathing space due to the fact that many people were coming into hospital needing beds due to influenza and other respiratory conditions,' he said. It comes as flu vaccine rates across the country remain low, with more than 8200 people in NSW testing positive for the flu in the week ending August 2. NSW chief health officer Kerry Chant said because the majority of people do not test for the flu, the figures are likely to be significantly higher. 'Everyone aged six months or older is recommended to get their flu vaccine, even previously healthy children and adults can experience severe complications from influenza,' she said. 'It's not too late to get vaccinated, getting the flu vaccine is quick, easy and recommended for everyone aged six months or older.' Dr Chant said despite the flu season nearing an end, she still urged everyone to get vaccinated. 'Influenza is a serious illness that can cause pneumonia, make chronic underlying medical conditions like diabetes, lung and heart disease much worse requiring hospital admission, and cause death,' she said. 'Complications can occur in anyone but are more likely in those at higher risk of severe illness.' In Queensland all residents are able to access the flu vaccination for free. 'Getting vaccinated not only protects individuals but also helps prevent the spread of influenza within the community,' Mr Owen said. The flu vaccine is free for NSW, WA, South Australian and Victorian residents aged six months to five years, pregnant women, Aboriginal people aged six months and over, residents over 65 and those with chronic health conditions.


Perth Now
11 hours ago
- Perth Now
Deputy Premier shock stance on flu rates
Health authorities are urging Australians to still get a flu shot but Queensland Deputy Premier Jarrod Bleijie says he is satisfied with his state's flu vaccine rates, which have toppled to new lows amid increasing flu-related hospitalisations. The state is facing a surge in infections this flu season, with more than 44,000 lab-confirmed cases confirmed in the state this year – 20 per cent higher than the year before. Queensland Health reported 106 flu-related deaths this year until August 9, which is 12 more than the same time last year. Flu vaccine rates are low among Queenslanders. NewsWire/Ian Currie Credit: News Corp Australia Pharmacy Guild of Australia president Chris Owen said 86 per cent of people hospitalised with the flu had not been vaccinated. 'You can't argue with the numbers,' he said in a statement, adding '86 per cent of people hospitalised with flu weren't vaccinated and 90 per cent of reported cases hadn't had the vaccine'. 'The message is clear: get to your community pharmacy and get vaccinated.' Queensland Deputy Premier Jarrod Bleijie refused to disclose whether he had the jab. Dan Peled / NewsWire Credit: News Corp Australia On Tuesday, Mr Bleijie told reporters his vaccination status was a 'private matter between me and my doctor'. 'We're not going to be a government, like former governments, dictating what people do in their own homes, their own lives or with their doctors,' he said, referring to Covid-19 restrictions and vaccination mandates. 'If people want to get the flu vaccination they are entitled to do that, I'm not going to dictate whether they should do it or not. 'We will deal with the influx of people in the hospitals, just as the health minister has been doing, with our wonderful doctors and nurses on the frontline.' Some hospitals in Queensland have had to postpone elective surgeries due the increase in flu cases. NewsWire/Ian Currie Credit: News Corp Australia Australian Medical Association president Nick Yim said the increased flu-related cases were adding to the already overrun healthcare system. 'The cases are rising, hospitalisations are rising due to influenza and that's due to the fact that many people aren't vaccinated,' Dr Yim told Weekend Today. 'And that, unfortunately, is putting pressure on our healthcare system.' He said hospitals were forced to postpone elective surgeries due to the increasing number of flu cases. 'The reason why we had to postpone elective surgery was to give a bit of breathing space due to the fact that many people were coming into hospital needing beds due to influenza and other respiratory conditions,' he said. Flu cases are also increasing in NSW. NewsWire/Ian Currie Credit: News Corp Australia It comes as flu vaccine rates across the country remain low, with more than 8200 people in NSW testing positive for the flu in the week ending August 2. NSW chief health officer Kerry Chant said because the majority of people do not test for the flu, the figures are likely to be significantly higher. 'Everyone aged six months or older is recommended to get their flu vaccine, even previously healthy children and adults can experience severe complications from influenza,' she said. 'It's not too late to get vaccinated, getting the flu vaccine is quick, easy and recommended for everyone aged six months or older.' NSW chief health officer Kerry Chant urged residents to get vaccinated against the flu/. NewsWire / Monique Harmer Credit: News Corp Australia Dr Chant said despite the flu season nearing an end, she still urged everyone to get vaccinated. 'Influenza is a serious illness that can cause pneumonia, make chronic underlying medical conditions like diabetes, lung and heart disease much worse requiring hospital admission, and cause death,' she said. 'Complications can occur in anyone but are more likely in those at higher risk of severe illness.' In Queensland all residents are able to access the flu vaccination for free. 'Getting vaccinated not only protects individuals but also helps prevent the spread of influenza within the community,' Mr Owen said. The flu vaccine is free for NSW, WA, South Australian and Victorian residents aged six months to five years, pregnant women, Aboriginal people aged six months and over, residents over 65 and those with chronic health conditions.


The Advertiser
13 hours ago
- The Advertiser
'Meteoric rise' in medicinal cannabis prescriptions signals serious review
Cowboy doctors have been put on notice, as telehealth services prescribing unapproved medicinal cannabis to seniors and other vulnerable Australians come under the microscope. Experts have welcomed a move by the government's Therapeutic Goods Administration (TGA) to review the safety and regulatory framework for medicinal cannabis products after increasing public and professional concern. The Australian Medical Association (AMA) said cannabis products are being prescribed at "alarming rates through direct-to-consumer telehealth models". Victorian MP and user of medicinal cannabis, David Ettershank, welcomed the review which includes a callout for public comment, and said it was "long overdue". "There has been a meteoric rise in the use of medicinal cannabis, and that is clear from all the data from the state and federal levels," he told The Senior. "The seniors' market is one of the fastest growing sectors for the medicinal cannabis industry, because of its ability to help with pain, arthritis, stress and sleep management." Read more from The Senior: Mr Ettershank said it's been a "Godsend" to be able to be prescribed approved medicinal cannabis to treat his auto-immune condition Polymyalgia Rheumatica, and ongoing chronic back pain from an injury, though admits it's not a "miracle cure for all ailments". The Senior understands only two medicinal cannabis products have been approved by the TGA, meaning many other products are accessed through the unapproved goods scheme. "Telehealth is an important mechanism to improve access to health services - but these direct-to-consumer, single-issue models lack clear referral pathways or a feedback loop to GPs and as the TGA has acknowledged, this requires much broader consideration by government," said AMA President Dr Danielle McMullen. "We are seeing increasing reports of patient harm from cannabis, including psychosis, so this current surge in prescriptions is highly concerning ...Clearly, the health landscape has changed dramatically in Australia, so it is vital we look at our regulatory settings and find out what needs to be done to address any gaps." Product-specific telehealth services are one of three key issues raised by the TGA. Other key issues include the safety risks of the products and whether there are appropriate regulations oversight of unapproved medicinal cannabis products being accessed via the Special Access Scheme and Authorised Prescriber Scheme. Like every industry, Mr Ettershank said, there will always be people who do the wrong thing for greed or act improperly, though from his own experience he has found practitioners take their responsibilities very seriously. "It's a relatively new industry, having only been around for 10 years, and it is appropriate that we pause occasionally to reflect on what is happening," he said. "I'm concerned that the scope of their consultation is limited, and it is not an inquiry by multiple agencies .... I'd like to see a holistic approach to regulation, reform, safety and quality in the medicinal cannabis sector, but we look forward to participating in the consultation." Further details on the consultation can be found at For enquiries relating to this public consultation, please email MedicinalCannabisReforms@ The closing date for this consultation is 23.59 AEST on October 7 2025. All submissions received by the deadline, will be considered by the TGA. Cowboy doctors have been put on notice, as telehealth services prescribing unapproved medicinal cannabis to seniors and other vulnerable Australians come under the microscope. Experts have welcomed a move by the government's Therapeutic Goods Administration (TGA) to review the safety and regulatory framework for medicinal cannabis products after increasing public and professional concern. The Australian Medical Association (AMA) said cannabis products are being prescribed at "alarming rates through direct-to-consumer telehealth models". Victorian MP and user of medicinal cannabis, David Ettershank, welcomed the review which includes a callout for public comment, and said it was "long overdue". "There has been a meteoric rise in the use of medicinal cannabis, and that is clear from all the data from the state and federal levels," he told The Senior. "The seniors' market is one of the fastest growing sectors for the medicinal cannabis industry, because of its ability to help with pain, arthritis, stress and sleep management." Read more from The Senior: Mr Ettershank said it's been a "Godsend" to be able to be prescribed approved medicinal cannabis to treat his auto-immune condition Polymyalgia Rheumatica, and ongoing chronic back pain from an injury, though admits it's not a "miracle cure for all ailments". The Senior understands only two medicinal cannabis products have been approved by the TGA, meaning many other products are accessed through the unapproved goods scheme. "Telehealth is an important mechanism to improve access to health services - but these direct-to-consumer, single-issue models lack clear referral pathways or a feedback loop to GPs and as the TGA has acknowledged, this requires much broader consideration by government," said AMA President Dr Danielle McMullen. "We are seeing increasing reports of patient harm from cannabis, including psychosis, so this current surge in prescriptions is highly concerning ...Clearly, the health landscape has changed dramatically in Australia, so it is vital we look at our regulatory settings and find out what needs to be done to address any gaps." Product-specific telehealth services are one of three key issues raised by the TGA. Other key issues include the safety risks of the products and whether there are appropriate regulations oversight of unapproved medicinal cannabis products being accessed via the Special Access Scheme and Authorised Prescriber Scheme. Like every industry, Mr Ettershank said, there will always be people who do the wrong thing for greed or act improperly, though from his own experience he has found practitioners take their responsibilities very seriously. "It's a relatively new industry, having only been around for 10 years, and it is appropriate that we pause occasionally to reflect on what is happening," he said. "I'm concerned that the scope of their consultation is limited, and it is not an inquiry by multiple agencies .... I'd like to see a holistic approach to regulation, reform, safety and quality in the medicinal cannabis sector, but we look forward to participating in the consultation." Further details on the consultation can be found at For enquiries relating to this public consultation, please email MedicinalCannabisReforms@ The closing date for this consultation is 23.59 AEST on October 7 2025. All submissions received by the deadline, will be considered by the TGA. Cowboy doctors have been put on notice, as telehealth services prescribing unapproved medicinal cannabis to seniors and other vulnerable Australians come under the microscope. Experts have welcomed a move by the government's Therapeutic Goods Administration (TGA) to review the safety and regulatory framework for medicinal cannabis products after increasing public and professional concern. The Australian Medical Association (AMA) said cannabis products are being prescribed at "alarming rates through direct-to-consumer telehealth models". Victorian MP and user of medicinal cannabis, David Ettershank, welcomed the review which includes a callout for public comment, and said it was "long overdue". "There has been a meteoric rise in the use of medicinal cannabis, and that is clear from all the data from the state and federal levels," he told The Senior. "The seniors' market is one of the fastest growing sectors for the medicinal cannabis industry, because of its ability to help with pain, arthritis, stress and sleep management." Read more from The Senior: Mr Ettershank said it's been a "Godsend" to be able to be prescribed approved medicinal cannabis to treat his auto-immune condition Polymyalgia Rheumatica, and ongoing chronic back pain from an injury, though admits it's not a "miracle cure for all ailments". The Senior understands only two medicinal cannabis products have been approved by the TGA, meaning many other products are accessed through the unapproved goods scheme. "Telehealth is an important mechanism to improve access to health services - but these direct-to-consumer, single-issue models lack clear referral pathways or a feedback loop to GPs and as the TGA has acknowledged, this requires much broader consideration by government," said AMA President Dr Danielle McMullen. "We are seeing increasing reports of patient harm from cannabis, including psychosis, so this current surge in prescriptions is highly concerning ...Clearly, the health landscape has changed dramatically in Australia, so it is vital we look at our regulatory settings and find out what needs to be done to address any gaps." Product-specific telehealth services are one of three key issues raised by the TGA. Other key issues include the safety risks of the products and whether there are appropriate regulations oversight of unapproved medicinal cannabis products being accessed via the Special Access Scheme and Authorised Prescriber Scheme. Like every industry, Mr Ettershank said, there will always be people who do the wrong thing for greed or act improperly, though from his own experience he has found practitioners take their responsibilities very seriously. "It's a relatively new industry, having only been around for 10 years, and it is appropriate that we pause occasionally to reflect on what is happening," he said. "I'm concerned that the scope of their consultation is limited, and it is not an inquiry by multiple agencies .... I'd like to see a holistic approach to regulation, reform, safety and quality in the medicinal cannabis sector, but we look forward to participating in the consultation." Further details on the consultation can be found at For enquiries relating to this public consultation, please email MedicinalCannabisReforms@ The closing date for this consultation is 23.59 AEST on October 7 2025. All submissions received by the deadline, will be considered by the TGA. Cowboy doctors have been put on notice, as telehealth services prescribing unapproved medicinal cannabis to seniors and other vulnerable Australians come under the microscope. Experts have welcomed a move by the government's Therapeutic Goods Administration (TGA) to review the safety and regulatory framework for medicinal cannabis products after increasing public and professional concern. The Australian Medical Association (AMA) said cannabis products are being prescribed at "alarming rates through direct-to-consumer telehealth models". Victorian MP and user of medicinal cannabis, David Ettershank, welcomed the review which includes a callout for public comment, and said it was "long overdue". "There has been a meteoric rise in the use of medicinal cannabis, and that is clear from all the data from the state and federal levels," he told The Senior. "The seniors' market is one of the fastest growing sectors for the medicinal cannabis industry, because of its ability to help with pain, arthritis, stress and sleep management." Read more from The Senior: Mr Ettershank said it's been a "Godsend" to be able to be prescribed approved medicinal cannabis to treat his auto-immune condition Polymyalgia Rheumatica, and ongoing chronic back pain from an injury, though admits it's not a "miracle cure for all ailments". The Senior understands only two medicinal cannabis products have been approved by the TGA, meaning many other products are accessed through the unapproved goods scheme. "Telehealth is an important mechanism to improve access to health services - but these direct-to-consumer, single-issue models lack clear referral pathways or a feedback loop to GPs and as the TGA has acknowledged, this requires much broader consideration by government," said AMA President Dr Danielle McMullen. "We are seeing increasing reports of patient harm from cannabis, including psychosis, so this current surge in prescriptions is highly concerning ...Clearly, the health landscape has changed dramatically in Australia, so it is vital we look at our regulatory settings and find out what needs to be done to address any gaps." Product-specific telehealth services are one of three key issues raised by the TGA. Other key issues include the safety risks of the products and whether there are appropriate regulations oversight of unapproved medicinal cannabis products being accessed via the Special Access Scheme and Authorised Prescriber Scheme. Like every industry, Mr Ettershank said, there will always be people who do the wrong thing for greed or act improperly, though from his own experience he has found practitioners take their responsibilities very seriously. "It's a relatively new industry, having only been around for 10 years, and it is appropriate that we pause occasionally to reflect on what is happening," he said. "I'm concerned that the scope of their consultation is limited, and it is not an inquiry by multiple agencies .... I'd like to see a holistic approach to regulation, reform, safety and quality in the medicinal cannabis sector, but we look forward to participating in the consultation." Further details on the consultation can be found at For enquiries relating to this public consultation, please email MedicinalCannabisReforms@ The closing date for this consultation is 23.59 AEST on October 7 2025. All submissions received by the deadline, will be considered by the TGA.